BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 1999
View Archived Issues
Priority review status assigned to Rapamune immunosuppressive therapy
Read More
Pediatric use of Maxipime approved by the FDA
Read More
Roberts and Yuhan enter distribution agreement for Agrylin in Korea
Read More
Alza launches Ditropan XL in the U.S.
Read More
GABA-A ligands useful for treating CNS disorders
Read More
Tachykinin antagonists claimed by HMR for asthma, cough, bronchitis and pain
Read More
New series of NHE inhibitors in development at Synthelabo
Read More
Enzon initiates phase III trials of PEG-Intron/Rebetol combination therapy for hepatitis C
Read More
Improved salts of ACE inhibitors prepared at NicOx
Read More
Bayer describes production and use of 2,9-disubstituted purin-6-ones
Read More
Schering discloses new leukotriene antagonists particularly useful as dermatological products
Read More
Genetics Kenkyusho and Yamanouchi to continue development of joint venture products separately
Read More
Phase I clinical trial of novel cervical dysplasia Rx from StressGen
Read More
Kirin to restart clinical trials of TPO
Read More
Clinical trials for Japanese immunosuppressant begin in Europe
Read More
KRH-594, a new angiotensin antagonist, evaluated in animal models of hypertension
Read More
Genome Therapeutics achieves milestone in asthma alliance with Schering-Plough
Read More
Cantab completes acquisition of drug addiction programs from ImmuLogic
Read More
New immunomodulator LK-423 possesses unique pharmacological properties
Read More
Boehringer Ingelheim seeks E.U. marketing approval for non-CFC respiratory device
Read More
Cephalon's narcolepsy treatment launched in Ireland
Read More
Moderate drinking reported to protect against ischemic stroke
Read More
Ontogen completes phase I study of MDR-modulating compound
Read More
Ontogeny enters diabetes research collaboration with Becton Dickinson
Read More